169175 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types Stem cells
TRANSIENT REPORTERS AND METHODS FOR BASE EDITING ENRICHMENT
#2PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES COMPRISING HIGHLY POTENT STEM CELLS EXPRESSING TIMP-1, MCP-1, GROa, AND IL-6, AND METHOD FOR SELECTING HIGHLY POTENT STEM CELLS
#3ECTODERMAL MESENCHYMAL STEM CELLS AND METHOD FOR PRODUCING SAME
#4IN VITRO CONSTRUCT USEFUL FOR DRUG TOXICITY SCREENING
#5METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#6Methods of Producing and Using Avian Embryonic Stem Cells and Avian Telencephalic Organoids
#7MMP-14 POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#8HIGH-THROUGHPUT AUTOMATION OF ORGANOIDS FOR IDENTIFYING THERAPEUTIC STRATEGIES
#9CD123 AND CD200 AS MARKERS FOR THE DIAGNOSIS AND IMMUNE-ERADICATION OF LEUKEMIC STEM CELLS (LSCS)
#10XENO-FREE GENERATION OF TISSUE-SPECIFIC PROGENITOR CELLS
#11PRODUCTION OF REPROGRAMMED PLURIPOTENT CELLS
#12CELL POPULATIONS OF CD31-POSITIVE, CD45-NEGATIVE, CD200-POSITIVE MAMMALIAN CELLS AND USE THEREOF
#13METHOD OF MAKING IN VIVO HUMAN SMALL INTESTINE ORGANOIDS FROM PLURIPOTENT STEM CELLS
#14METHODS FOR STRATIFICATION OF PARKINSON'S DISEASE PATIENTS, SYSTEMS AND USES THEREOF
#15Human Homogeneous Amniotic Fluid Stem Cell Lines And Uses Thereof
#16SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF
#17IN VITRO QUALITY SCREENING OF HUMAN CORNEAL STROMAL STEM CELLS FOR CELL-BASED THERAPY OF CORNEAL SCARRING
#18LEUKEMIA-RELATED MARKER AND USE THEREOF
#19EPIGENETIC TARGETS IN CLONAL HEMATOPOIESIS
#20PIG EMBRYO-DERIVED PLURIPOTENT STEM CELLS AND USE THEREOF
#21TRAINED NEURONAL CELL CULTURES FOR DRUG TESTING
#22SUPERCENTENARIAN INDUCED PLURIPOTENT STEM (sciPS) CELLS AND METHODS OF MAKING AND USING THEREOF
#23COMPOSITIONS COMPRISING A ZIM3 EFFECTOR AND METHODS OF USE THEREOF
#24HUMAN TROPHOBLAST STEM CELLS AND USES THEREOF
#25REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION
#26METHOD OF SCREENING FOR AGENTS FOR DIFFERENTIATING STEM CELLS
#27PLATFORM FOR TARGET DISCOVERY AND METHODS OF USE THEREOF
#28SMALL MOBILE STEM CELLS (SMS) AND USES THEREOF
#29METHODS FOR TREATING DISEASE ASSOCIATED WITH SENESCENCE
#30METHOD FOR DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER ON BASIS OF ACTIVITY REGULATION MECHANISM OF DORMANT NEURAL STEM CELL
#31ASSAY FOR EXTRINSIC INHIBITION
#32Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereof
#33NME INHIBITORS AND METHODS OF USING NME INHIBITORS
#34Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
#35METHOD OF MAKING IN VIVO HUMAN SMALL INTESTINE ORGANOIDS FROM PLURIPOTENT STEM CELLS
#36CELL ANALYSIS
#37GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLAST STEM CELLS
#38COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS
#39Methods and Compositions for Diagnosing and Treating Rare Genetic DIseases
#40Pharmaceuticals That Promote Functional Regeneration of Damaged Tissues
#41METHOD OF PRODUCING CANCER STEM CELLS
#42NOVEL METHODS
#43CORTICAL INTERNEURONS AND OTHER NEURONAL CELLS PRODUCED BY THE DIRECTED DIFFERENTIATION OF PLURIPOTENT AND MULTIPOTENT CELLS
#44Monitoring Cancer Stem Cells
#45METHODS FOR NUCLEAR REPROGRAMMING USING SYNTHETIC TRANSCRIPTION FACTORS
#46Therapeutic Substances, their Preparation and Diagnostic Procedure
#47Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)
#48POTENCY ASSAY
#49ASSAY FOR DRUG DISCOVERY BASED ON IN VITRO DIFFERENTIATED CELLS
#50APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER IMMUNE DYSREGULATION DISEASES
#51SYSTEMS AND METHODS FOR ASSESSING PATIENT-SPECIFIC RESPONSE TO THROMBOPOIETINRECEPTOR AGONISTS
#52SMALL MOBILE STEM CELLS (SMS) AND USES THEREOF
#53PH MEASUREMENT METHOD AND PH MEASUREMENT DEVICE
#54ISOLATION OF FUSION-COMPETENT MYOBLASTS AND THERAPEUTIC APPLICATIONS THEREOF RELATED TO MUSCULAR DYSTROPHY
#55ALLOGENEIC COMPOSITION FOR THE TREATMENT OF CNS DISORDERS
#56METHODS FOR DETECTING, QUANTIFYING AND MONITORING IMMUNE-CELL MEDIATED CYTOTOXICITY OF CELL POPULATIONS COMPROMISING IMMUNE CELLS AND/OR STEM CELLS
#57COMPOSITIONS AND METHODS IDENTIFYING AND USING STEM CELL DIFFERENTIATION MARKERS
#58Generation of neural stem cells from human trophoblast stem cells
#59Assay
#60NME INHIBITORS AND METHODS OF USING NME INHIBITORS
#61IMPROVED STEM CELL POPULATIONS FOR ALLOGENEIC THERAPY
#62METHOD FOR ENHANCING TUMOR GROWTH
#63Synthetic Lethality Screening Platform for Cells Undergoing ALT
#64Culture Method for Head and Neck Organoids
#65Culture Medium
#66Use of mesenchymal stem cells in treating immune-related diseases
#67Xeno-free generation of tissue-specific progenitor cells
#68NOVEL REPROGRAMMING METHOD
#69TRANSGENIC MODELS FOR STEM CELL THERAPIES
#70Composition comprising material for regulating OCT4 modification to repress stemness
#71Bioreactor System
#72DRUG DISCOVERY AND EARLY DISEASE IDENTIFICATION PLATFORM USING ELECTRONIC HEALTH RECORDS, GENETICS AND STEM CELLS
#73Method for Producing Stem/Precursor Cells, By Using Low Molecular Weight Compound, From Cells Derived From Endodermal Tissue or Organ
#74Methods of making hydraulic fracturing fluids and use thereof
#75METHODS FOR TREATING CARDIAC INJURY
#76TRANSIENT REPORTERS AND METHODS FOR BASE EDITING ENRICHMENT
#77METHODS AND COMPOSITIONS FOR CHARACTERIZATION OF GLIOBLASTOMA MULTIFORME TUMORS AND CANCER STEM CELLS
#78MSC prediction algorithm
#79Fluorescent multiplex cell flow systems and methods
#80Image processing device, image processing method, program, and evaluation method
#81High-throughput automation of organoids for identifying therapeutic strategies
#82HIGH THROUGHPUT DRUG SCREENING OF CANCER STEM CELLS
#83Human trophoblast stem cells and uses thereof
#84Methods for Identifying Two or More Populations Having Different Responses to Chemical or Biological Agents
#85INDUCTIVE REGENERATION OF THE AIRWAY BY TRANSCRIPTIONAL FACTOR MODULATION OF GLANDULAR MYOEPITHELIAL STEM CELLS
#86METHODS OF CANCER IMMUNOTHERAPY
#87METHODS AND COMPOSITIONS FOR INDUCING HEMATOPOIETIC CELL DIFFERENTIATION
#88Methods and compositions for inducing hematopoietic cell differentiation
#89ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE
#90Delta133P53Beta and Delta133P53Gamma isoforms are biomarkers of cancer stem cells
#91THERAPEUTIC SUBSTANCES, THEIR PREPARATION AND DIAGNOSTIC PROCEDURE
#92Human brown adipose derived stem cells and uses
#93IN VITRO METHOD FOR PROVIDING STEM CELL DERIVED CARDIOMYOCYTES
#94New Uses Of Mammalian Muscle-Derived Stem Cells
#95Production of fertile XY female animals by silencing of genes on the Y chromosome
#96Supercentenarian induced pluripotent stem (sciPS) cells and methods of making and using thereof
#97Method for inducing osteogenic differentiation
#98Methods and compositions for inducing hematopoietic cell differentiation
#99DIRECTED DIFFERENTIATION OF ASTROCYTES FROM HUMAN PLURIPOTENT STEM CELLS FOR USE IN DRUG SCREENING AND THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#100Non-invasive, in vitro functional tissue assay systems
#101Methods and compositions for inducing hematopoietic cell differentiation
#102Differentiation of pluripotent cells into microglial cells expressing IBA-1
#103Methods for nuclear reprogramming using synthetic transcription factors
#104Cancer stem cell population and method for production thereof
#105Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereof
#106GRP78-derived peptide for identifying high-efficiency stem cells
#107CELL POTENCY ASSAY
#108METHOD OF FABRICATING CELL ARRAYS AND USES THEREOF
#109SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF
#110Human trophoblast stem cells and uses thereof
#111Agent for accelerating maturation or aging of cells
#112Anti-mitochondrial inhibitors for oncogenic Ras and Myc
#113ECTODERMAL MESENCHYMAL STEM CELLS AND METHOD FOR PRODUCING SAME
#114PROTECTION OF THE VASCULAR ENDOTHELIUM FROM IMMUNOLOGICALLY MEDIATED CYTOTOXIC REACTIONS WITH HUMAN CD34-NEGATIVE PROGENITOR CELLS
#115Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue
#116METHODS AND COMPOSITIONS FOR MOBILIZING STEM CELLS
#117METHOD FOR EVALUATING EFFECT OF CYTOKINE ON METABOLIC ACTIVITY OF CYTOCHROME P450, AND DRUG SCREENING METHOD
#118AGENT FOR PROMOTING MIGRATION OF PLURIPOTENT STEM CELLS
#119Methods for Enriching Pluripotent Stem Cell-Derived Cardiomyocyte Progenitor Cells and Cardiomyocyte Cells based on SIRPA Expression
#120Synthetic binder of breast cancer stem cells
#121CANCER MARKERS AND METHODS OF USE THEREOF
#122METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO GERM CELLS
#123CARDIAC STEM CELLS AND METHODS OF IDENTIFYING AND USING THE SAME
#124Inflammatory bowel disease stem cells, agents which target IBD stem cells, and uses related thereto
#125Human homogeneous amniotic fluid stem cell lines and uses thereof
#126Methods for Producing Enteroendocrine Cells That Make and Secrete Insulin
#127Method of producing cancer stem cells
#128METHOD
#129In vitro fibrosis model, preparing method therefor, and use thereof
#130METHOD FOR SCREENING FOR PLURIPOTENT STEM CELL GROWTH-PROMOTING FACTOR
#131Method For Selecting High-Efficacy Stem Cell By Using Downregulation In Expression Or Activity Of Socs
#132ORGANOID ARRAYS
#133Reprogramming cell aging
#134GENETICALLY-TAGGED STEM CELL LINES AND METHODS OF USE
#135COMPOSITIONS AND METHODS FOR LUNG REGENERATION
#136Method For Sorting Highly Effective Stem Cells For Treating Immune Disorder
#137MEANS AND METHODS FOR TREATING PARKINSON'S DISEASE
#138METHOD FOR INCREASING NUMBER OF STEM CELLS IN HUMAN OR ANIMAL BODIES
#139IgG type monoclonal antibodies specifically binding to odontoblast surface
#140CELL CULTURES AND USE THEREOF
#141Methods of differentiating stem cells by modulating MIR-124
#142IN VITRO METHOD FOR IDENTIFICATION AND ANALYSIS OF PROTEINS WITH STEM CELL FUNCTION USING A THREE-DIMENSIONAL CELL CULTURE MODEL OF THE SWEAT GLAND
#143Embryonic cell-based therapeutic candidate screening systems, models for Huntington's Disease and uses thereof
#144Generation of cancer stem cells and use thereof
#145ISOLATION OF NON-EMBRYONIC STEM CELLS AND USES THEREOF
#146THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#147METHODS FOR SELECTING IMPROVED STEM CELL FOR TREATING INTRAVENTRICULAR HEMORRHAGE OF PREMATURE INFANTS
#148Human brown adipose derived stem cells and uses
#149PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS
#150METHODS AND DEVICES FOR HIGH THROUGHPUT SCREENING OF CONDITIONS AFFECTING STEM CELL DIFFERENTIATION
#151EVALUATION METHOD FOR DIFFERENTIATION STATE OF CELLS
#152METHODS FOR GENERATING AUGMENTED STEM CELL-DERIVED BETA CELLS AND USES THEREOF
#153Induction of differentiation of induced pluripotent stem cells into intestinal epithelial cells
#154Mobilization of pluripotent stem cells for ischemic cerebral infarction
#155Reprogramming-based models of neurodevelopmental disorders and uses thereof
#156METHOD OF MODULATING SURVIVAL AND STEMNESS OF CANCER STEM CELLS BY MDA-9/SYNTENIN (SDCBP)
#157Method of determining cellular protein homeostasis
#158Small mobile stem cells (SMS) and uses thereof
#159Monitoring Cancer Stem Cells
#160SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF
#161Compositions and methods for modulating stem cells and uses thereof
#162Isolation of fusion-competent myoblasts and therapeutic applications thereof related to muscular dystrophy
#163Method for screening for pluripotent stem cell growth-promoting factor
#164METHOD OF PRODUCING FULL THICKNESS SKIN HAVING SKIN ACCESSORY ORGANS
#165MULTI-ORGAN CELL CULTURE SYSTEM AND METHODS OF USE THEREOF
#166PROPHYLACTIC AND THERAPEUTIC AGENTS FOR FGFR3 DISEASES AND SCREENING METHOD FOR THE SAME
#167Screening method
#168THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS
#169Intestinal epithelioid cells
#170EXPANSION OF RENEWABLE STEM CELL POPULATIONS
#171Methods and compositions for inducing hematopoietic cell differentiation
#172NON-INVASIVE, IN VITRO FUNCTIONAL TISSUE ASSAY SYSTEMS
#173METHODS FOR TREATING CARDIAC INJURY
#174Methods for Establishing Threshold Limits for a Chemical or Biological Agent in a Target Species
#175Xeno-free generation of tissue-specific progenitor cells
#176CELL POTENCY ASSAY
#177Method of screening for agents for differentiating stem cells
#178Compostition for reprogramming cells
#179Human trophoblast stem cells and uses thereof
#180DIRECTED DIFFERENTIATION OF ASTROCYTES FROM HUMAN PLURIPOTENT STEM CELLS FOR USE IN DRUG SCREENING AND THE TREATMENT OF AMYOTROPHIC LATERIAL SCLEROSIS (ALS)
#181AGE-MODIFIED CELLS AND METHODS FOR MAKING AGE-MODIFIED CELLS
#182METHODS AND COMPOSITIONS FOR CHARACTERIZATION OF GLIOBLASTOMA MULTIFORME TUMORS AND CANCER STEM CELLS
#183Method for evaluating content of mesenchymal stem cells in cell-containing sample
#184Pharmaceutical composition for inhibiting resistance against anticancer drugs of patient suffering from ovarian cancer comprising NAG-1 inhibitor as active ingredient
#185Method for screening induced pluripotent stem cells
#186Cell-permeable reprogramming factor (iCP-RF) recombinant protein and use thereof
#187Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells
#188Cardiac stem cells and methods of identifying and using the same
#189Cosmetic Method and Dermatological Topical Agent for Use Therein, Migration Imparting Agent, and Method for Screening Components for Use in Cosmetic Method for Improving Skin State
#190SELECTIVE INHIBITORS OF UNDIFFERENTIATED CELLS
#191METHOD FOR CRYOPRESERVATION OF CARDIOCYTES DERIVED FROM PLURIPOTENT STEM CELLS OR MESENCHYMAL STEM CELLS DERIVED FROM ADIPOSE TISSUE OR BONE MARROW
#192Liquid biopsy detection of leukemia using closed-loop microfluidics
#193METHODS AND PRODUCTS FOR ENRICHING AND ISOLATING STEM CELLS
#194Imaging apparatus and method and imaging control program
#195Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios
#196Arrays of discrete cell culture microenvironments, methods of making such arrays and uses thereof
#197HIGH THROUGHPUT CARDIOTOXICITY SCREENING PLATFORM
#198Direct conversion method of somatic cell into Hepatic stem cell, hepatic cell, or cholangiocyte
#199GENERATION OF FUNCTIONAL CELLS FROM STEM CELLS
#200Cancer stem cell targeting peptide and use thereof
#201Methods for differentiating pluripotent cells
#202Method and kit for detecting stem cell
#203METHOD FOR INCREASING NUMBER OF STEM CELLS IN HUMAN OR ANIMAL BODIES
#204METHOD FOR INCREASING NUMBER OF STEM CELLS IN HUMAN OR ANIMAL BODIES
#205Screening method
#206Employing human adipose-derived stem cells to propagate serum-derived hepatitis C virus and use thereof
#207Method of differentiating human pluripotent stem cells into primitive macrophages
#208Compound for identifying pluripotent cells
#209AGE-MODIFIED CELLS AND METHODS FOR MAKING AGE-MODIFIED CELLS
#210Methods for non-invasive profiling of stem cell differentiation
#211Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells
#212METHODS FOR MOBILISING POPULATIONS OF STEM CELLS
#213Long term hematopoietic stem cell specific reporter mouse and uses thereof
#214Method for determining state of differentiation of stem cells, and novel differentiation marker used therefor
#215PRO-ANGIOGENIC AND ANTI-ANGIOGENIC HEMATOPOIETIC PROGENITOR CELL POPULATIONS
#216Antibodies that specifically bind to TIM3
#217Genetically modified rat derived from rat embryonic stem cell
#218Platform and Methods for Analyzing Effects of Genetics, Age and Environment in Stimulus-Response Studies Using Induced Pluripotent Stem Cells
#219Methods for Conducting Stimulus-Response Studies with Induced Pluripotent Stem Cells Derived from Perinatal Cells or Tissues
#220Artificial three-dimensional microenvironment niche culture and methods of using the same
#221Method for reestablishment of pluripotent stem cells
#222SYSTEMS AND METHODS TO DETECT STEM CELL STRESS AND USES THEREOF
#223NOD2-DEPENDENT PATHWAY OF CYTOPROTECTION OF STEM CELLS
#224COMPOSITIONS AND METHODS FOR TREATING LUNG REMODELING DISEASES
#225Method of making in vivo human small intestine organoids from pluripotent stem cells
#226MODULATION OF GLOBOSERIES GLYCOSPHINGOLIPID SYNTHESIS AND CANCER BIOMARKERS
#227Culture medium
#228Method and kit for assessment of sodium channel-related anti- or pro-arrhythmic potential of compounds
#229Propeptide-luciferase fusion proteins and methods of use thereof
#230Method for screening induced pluripotent stem cells
#231METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#232Mesenchymal Stem Cell Diagnostic Testing
#233SCREENING METHOD
#234Methods for generating the inner ear and other cranial placode-derived tissues using pluripotent stem cells
#235Use of SUSD2 protein as marker
#236Method for determining undifferentiated state of pluripotent stem cells by culture medium analysis
#237Modulation of stem cells using zinc finger proteins
#238Fluorescent synthetic retinoids
#239Drug for the treatment of cholesterol accumulation disorders
#240DATA ANALYSIS OF CELLS UNDERGOING EXCITATION CONTRACTION COUPLING AS DETECTED ON REAL-TIME CELL ANALYSIS (RTCA) INSTRUMENTS
#241Identification of cancer stem cells markers and use of same for diagnosis and treatment
#242In vitro assays for assessing cell aging
#243Generation of neural stem cells from human trophoblast stem cells
#244Cancer stem cell targeting peptide and use thereof
#245Use of compounds inhibiting apelin / APJ / GP130 signaling for treating cancer
#246METHOD OF GENERATING MULTILINEAGE POTENTIAL CELLS FROM LYMPHOCYTES
#247Composition for inducing direct transdifferentiation of somatic cell into vascular progenitor cell, and use thereof
#248METHODS FOR DETERMINING THE EFFECTS OF COMPOUNDS ON JAK/STAT ACTIVITY
#249SUPERCENTENARIAN INDUCED PLURIPOTENT STEM (sciPS) CELLS AND METHODS OF MAKING AND USING THEREOF
#250GENERATION OF INDUCED PLURIPOTENT STEM (iPS) CELLS
#251Method for inducing differentiation of insulin-producing cells
#252Production of fertile XY female animals by silencing of genes on the Y chromosome
#253Methods of differentiating stem cells by modulating miR-124
#254Methods and compositions for targeting cancer stem cells
#255Methods for producing enteroendocrine cells that make and secrete insulin
#256Compositions and methods for modulating stem cells and uses thereof
#257PRODUCTION OF REPROGRAMMED PLURIPOTENT CELLS
#258Methods and pharmaceutical compositions for the treatment of beta-thalassemias
#259INDUCED PLURIPOTENT STEM CELL MODEL OF NOONAN SYNDROME AND USE THEREOF
#260SCREENING ASSAYS FOR IDENTIFYING DIFFERENTIATION-INDUCING AGENTS AND PRODUCTION OF DIFFERENTIATED CELLS FOR CELL THERAPY
#261Defined three-dimensional microenvironment for stem cell
#262ASSAYS AND MONITORING PARADIGMS FOR STEM CELL CULTURE
#263Induced pluripotent stem cell model for cardiofaciocutaneous syndrome and uses thereof
#264Cell assessment method, cell assessment device, and cell assessment program
#265Method of generating human pancreatic cells
#266Populations of mesenchymal stem cells that secrete neurotrophic factors
#267Methods and devices for high throughput screening of conditions affecting stem cell differentiation
#268Method for evaluating cell populations
#269Compositions, methods, and devices for treating disease
#270Prophylactic and therapeutic agents for FGFR3 diseases and screening method for the same
#271NME Inhibitors and Methods of Using NME Inhibitors
#272Use and identification of biomarkers for gastrointestinal diseases
#273Leukemic stem cell markers
#274Cancer markers and methods of use thereof
#275TRANSFORMED HUMAN PLURIPOTENT STEM CELLS AND ASSOCIATED METHODS
#276Xeno-free generation of tissue-specific progenitor cells
#277Method for preparation of induced dopaminergic progenitors using direct reprogramming
#278Bioreactor system
#279ISOLATION OF NON-EMBRYONIC STEM CELLS AND USES THEREOF
#280ASSAY FOR DRUG DISCOVERY BASED ON IN VITRO DIFFERENTIATED CELLS
#281Assay for drug discovery based on in vitro differentiated cells
#282Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells
#283Angiohematopoietic progenitor cells
#284STEM CELL MICROPARTICLES AND miRNA
#285ASSAY FOR SCREENING COMPOUNDS THAT SELECTIVELY DECREASE THE NUMBER OF CANCER STEM CELLS
#286Method for screening for pluripotent stem cell growth-promoting factor
#287Covalently-immobilized hydrogel arrays in multi-well plates
#288Methods for suppressing adipocyte differentiation
#289Methods for Predicting Responses to Chemical or Biological Substances
#290METHOD FOR SCREENING DRUGS FOR TREATING/PREVENTING MYELODYSPLASTIC SYNDROME, ETC.
#291Compositions and Methods Useful for Culturing Differentiable Cells
#292PLURIPOTENT STEM CELLS DERIVED FROM NON-CRYOPROTECTED FROZEN TISSUE AND METHODS FOR MAKING AND USING THE SAME
#293Small mobile stem cells (SMS) and uses thereof
#294Methods and compositions for mobilizing stem cells
#295ARRAYS OF DISCRETE CELL CULTURE MICROENVIRONMENTS, METHOD OF MAKING SUCH ARRAYS AND USES THEREOF
#296REPROGRAMMED CELLS AND METHODS OF PRODUCTION AND USE THEREOF
#297Cortical interneurons and other neuronal cells produced by the directed differentiation of pluripotent and multipotent cells
#298Age-modified cells and methods for making age-modified cells
#299METHODS AND MATERIALS FOR ASSESSING PLURIPOTENCY OF STEM CELL POPULATIONS
#300Generation of keratinocytes from pluripotent stem cells and maintenance of keratinocyte cultures